Part A Tight Junction Physiology	Part B Alba's Therapeutic Approach to Celiac Disease	Combined Part A & B

Barrier dysfunction has been implicated as a causal factor in many autoimmune and inflammatory diseases.   Alba’s discovery efforts are focused on the regulation of dysfunctional permeability through a variety of mechanisms, including through the use of permeability inhibitors, depicted in the videos above.

By inhibition of inappropriate permeability through a variety of mechanisms, Alba strives to modify disease progression while downregulating the associated inflammatory cascade.